• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • News
  • QMS/PMS

News


  • Moments
  • Regulations & Guidelines
  • Fast Track Update
  • QMS/PMS
  • Other News
  • NMPA Monthly Newsletter
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021

NMPA Strengthening The Supervision And Management Of Medical Device Registration

2022-02-27

In 2021, NMPA continues to strengthen the supervision and management of medical device registration. Class I filing surveillance…

NMPA Continues To Consolidate The Foundation Of Medical Device Registration Management

2022-02-27

In 2021, NMPA continues to consolidate the foundation of medical device registration management, ensuring the medical device developing…

NMPA Encourages High-quality Development Of Medical Device Industry

2022-02-23

In 2021, NMPA continues to encourage high-quality development of medical device industry through innovation pathway, priority pathway, real…

NMPA New Regulatory Framework Summary In 2021

2022-02-16

In 2021, China NMPA established new regulatory framework for medical device registration. The below is a list of…

China NMPA Newsletter – December 2021

2022-01-25

Inspirative Medical – A BradyKnows Company December 2021 China NMPA Newsletter Official Publication of BradyKnows 【Deadline】 2021 Annual…

NMPA On Issuing Relevant Technical Guidelines In December 2021

2022-01-20

In order to strengthen the supervision and guidance of medical device product registration and further improve the quality…

【Deadline】 2021 Annual Quality System Self-Inspection Report To China NMPA

2022-01-18

Dear Medical Device Manufacturers, Here is a kind REMINDER to manufacturers operating Class III medical devices in China,…

NMPA Collect Public Opinions On Termination Of Old GCP

2022-01-14

On Jan 12, 2022, NMPA issued a notice on its website to collect public opinions on termination of…

New Batch Of China Medical Device Catalogue Modification

2022-01-05

On Dec 27, 2021, Center for Medical Device Standardization Administration of NMPA published a notice to collect public…

NMPA Notice On Deadline Of Paying Review Fee For Registration

2022-01-05

On Dec 1, 2021, NMPA published a notice on the deadline of paying review fee for registration.  After…

China Continues To Enhance Post Market Surveillance On Medical Devices

2021-12-17

Since the implementation of Order 739 Regulations on Supervision and Administration of Medical Devices in June, 2021, China…

China NMPA Newsletter – November 2021

2021-12-15

Inspirative Medical – A BradyKnows Company November 2021 China NMPA Newsletter Official Publication of BradyKnows New E-filing Catalogue…
« Prev...246...1112131415...18...Next »
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7